Vincent Defour

Vincent Defour's public commentary circles around one repeated idea: the forces reshaping industries no longer arrive one at a time, and the real competitive edge lies in reading how they combine rather than simply spotting them. Writing about Food and Beverage, he puts it directly: "For decades, scale won in Food and Beverage. Biggest portfolio. Lowest cost. Widest reach. That logic is breaking" . His argument is that a single disruptive force is absorbable, but several converging at once expose structural weakness: "One shift absorbs into the structure you have. Several at once expose where it was never built for them" . This is not a claim that leaders are blind to change. He is explicit that most of them already see the individual pieces. What separates winners from laggards, in his framing, is sequencing and synthesis: "The hard part was never spotting them. Most leaders already can. The advantage belongs to whoever reads how they combine, and decides where to act first" . He frames this widening gap as the difference between "leading a shift and chasing it" , and treats concrete corporate moves, like PepsiCo reformulating ahead of regulation, as signals worth reading structurally rather than as isolated news: "that's a category being redrawn, and catching it early is the whole job" .

This same logic carries into his reading of retail and commerce, where he reframes the familiar AI-agent narrative around a harder question of ownership. Citing the projection that "By 2030, up to $385 billion of US commerce spending could run through AI agents" , he argues the real story is not the technology but the relocation of decision-making power: "The moment of influence used to belong to the shopper. Now it may belong to whatever system the shopper delegates to, and whoever controls that system's data" . He pushes past the obvious observation that agents are entering the purchase funnel to ask who actually owns that funnel going forward: "who ends up owning the agent, and the relationship once it's the one deciding for the shopper" . This is characteristic of his method: take a widely discussed trend, then locate the underexamined structural question sitting beneath it.

In pharma and biotech, he applies the same compounding-forces lens but adds a specific diagnosis of what makes the sector feel chaotic to its own leaders. He validates the frustration directly, "the feeling that the industry is moving in too many directions at once. And honestly, they are right" , before insisting the apparent chaos has an underlying order: "the directions are not random" . His core claim is that AI has stopped being a tool bolted onto discovery and has become foundational: "AI is not just accelerating discovery. It is becoming the operating infrastructure that runs R&D, man